News Story: Full Text
Sponsored By
Tocagen Clinical Trial
Please Click On The Above Banner For More Details
Braintumor Website

 

Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy

Al's Comment:

 This is one of the most exciting treatments in the pipeline, but it is only 1 patient.  We will keep an eye on this.


Posted on: 05/19/2017

Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740